Retraction | Published:

IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer

Oncogene volume 33, page 4450 (28 August 2014) | Download Citation

Retraction to: Oncogene (2014); doi:10.1038/onc.2014.158; published online 9 June 2014

The authors wish to retract this article due to concerns raised regarding some of the data presented in Figures 2, 4, 5, 6 and Supplementary Figures 6 and 7.

According to the data presented in Figures 1, 3 and 7, the major conclusion drawn from this article is still valid: IL-6 secreted by CAFs is causal factor for tamoxifen resistance in luminal breast cancer.

The authors are deeply regretful and apologize to the readers.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/onc.2014.224

Authors

  1. Search for X Sun in:

  2. Search for Y Mao in:

  3. Search for J Wang in:

  4. Search for L Zu in:

  5. Search for M Hao in:

  6. Search for G Cheng in:

  7. Search for Q Qu in:

  8. Search for D Cui in:

  9. Search for E T Keller in:

  10. Search for X Chen in:

  11. Search for K Shen in:

  12. Search for J Wang in:

Further reading